Prabhudas Lilladher's research report on UTI Asset Management Company
UTIAMC saw a weak quarter as operating yields at 13bps missed PLe by 5bps due to revenue miss of 5% and opex being higher to PLe by 9%. Other opex spike of 27% QoQ was due to one-time expenses, which is expected to normalize. Equity yields (75bps) declined by 7-8bps YoY in FY23; however, yield contraction in FY24/25E could be lesser than FY23 as lower yielding AuM now makes up for 80% of equity AuM. On a blended basis, we are factoring an average 2bps fall in yields in FY24/25 (5bps in FY23). We cut core earnings by 11% in FY24/25E as we trim revenue by ~4.0%. Valuation is undemanding at 11x on FY25E core EPS and we maintaining multiple at 14x on FY25E core EPS.
Outlook
We see two key levers for stock to re-rate beyond 14x, 1) distribution of excess cash to investors and 2) TATA AMC buying a majority stake in UTIAMC. We lower our TP from Rs830 to Rs770. Retain ‘BUY’.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.